Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Урології Та Нефрології Амн України, Институт Урологии И Нефрологии Амн УкраиныfiledCriticalІнститут Урології Та Нефрології Амн України
Priority to UA2000074556ApriorityCriticalpatent/UA38590A/en
Publication of UA38590ApublicationCriticalpatent/UA38590A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
The method for treating glomerulonephritis with anephrotic syndrome and hematuric component comprises the use of membrane-stabilizing therapy. The complex of membrane-stabilizing agents is used starting from the first month of the treatment. Starting from the second month, the antioxidant of plant origin and the inhibitor of angiotensin-converting enzyme are taken per os at the standard doses for 5 months.
UA2000074556A2000-07-282000-07-28Method for treating glomerulonephritis with anephrotic syndrome and hematuric component
UA38590A
(en)
Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter
Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc.